Department of Obstetrics and Gynecology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Int J Gynecol Cancer. 2010 Oct;20(7):1225-31. doi: 10.1111/IGC.0b013e3181ead337.
Lymphangiogenesis plays a key role in tumor growth, progression, and metastasis, yet few studies have investigated lymphatic vessel density (LVD) in cases of cervical cancer. The aim of this retrospective study was to evaluate intratumoral LVD, in addition to other histologic variables, in relation to lymph node metastases and survival of patients with stage IB to IIA cervical cancer after radical hysterectomy.
Between 2000 and 2008, 144 patients had a diagnosis of cervical uterine cancer and underwent radical hysterectomy. Tumor stages for these patients were identified according to the criteria of the International Federation of Gynecology and Obstetrics and included 84 stage IB1, 44 stage IB2, and 16 stage IIA cases. With an antibody directed against human podoplanin (D2-40), immunohistochemical staining was used to measure LVD. The correlation between LVD and clinicopathologic features of the resected tumors was analyzed.
Lymphatic vessel density was significantly higher in tumors less than 2 cm in diameter (P = 0.001) and in tumors with 1.0-cm-or-less depth of invasion (P = 0.007), with early stage (P = 0.001), and with negative lymph nodes (P = 0.05). After multivariate analysis, the predictive factors associated with lymph node metastases were depth of infiltration (P = 0.027), lymphovascular space invasion (P < 0.001), and parametrial involvement (P = 0.01). For patient death, the predictive factors were International Federation of Gynecology and Obstetrics stage (P = 0.017), histologic type (P = 0.010), lymph node status (P = 0.031), and histologic grade (P = 0.041). Lymphatic vessel density was not a predictive variable for lymph node metastasis or death.
Intratumoral LVD was greater in early cervical cancer (ie, smaller tumors, early clinical stage, and negative lymph nodes), and no relationship between LVD and lymph node metastases or survival was observed.
淋巴管生成在肿瘤的生长、进展和转移中起着关键作用,但很少有研究调查宫颈癌中的淋巴管密度(LVD)。本回顾性研究的目的是评估肿瘤内 LVD 以及其他组织学变量与接受根治性子宫切除术的 IB 期至 IIA 期宫颈癌患者的淋巴结转移和生存之间的关系。
2000 年至 2008 年间,有 144 名患者被诊断为宫颈癌并接受了根治性子宫切除术。这些患者的肿瘤分期根据国际妇产科联合会的标准确定,包括 84 例 IB1 期、44 例 IB2 期和 16 例 IIA 期。使用针对人 podoplanin(D2-40)的抗体进行免疫组织化学染色以测量 LVD。分析 LVD 与切除肿瘤的临床病理特征之间的相关性。
直径小于 2cm 的肿瘤(P=0.001)和浸润深度为 1.0cm 或以下的肿瘤(P=0.007)、早期肿瘤(P=0.001)和淋巴结阴性的肿瘤(P=0.05)的 LVD 显著较高。多变量分析后,与淋巴结转移相关的预测因素为浸润深度(P=0.027)、淋巴管血管侵犯(P<0.001)和宫旁受累(P=0.01)。对于患者死亡,预测因素为国际妇产科联合会分期(P=0.017)、组织学类型(P=0.010)、淋巴结状态(P=0.031)和组织学分级(P=0.041)。LVD 不是淋巴结转移或死亡的预测变量。
早期宫颈癌(即较小的肿瘤、早期临床分期和阴性淋巴结)的肿瘤内 LVD 更高,但 LVD 与淋巴结转移或生存之间没有关系。